BIOTON S.A. (WSE:BIO)
3.650
-0.030 (-0.82%)
Apr 3, 2025, 2:37 PM CET
BIOTON Revenue
In the year 2024, BIOTON had annual revenue of 207.76M PLN with 14.38% growth. BIOTON had revenue of 77.69M in the quarter ending December 31, 2024, with 63.48% growth.
Revenue
207.76M
Revenue Growth
+14.38%
P/S Ratio
1.52
Revenue / Employee
581.97K
Employees
359
Market Cap
315.98M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 207.76M | 26.13M | 14.38% |
Dec 31, 2023 | 181.64M | -51.52M | -22.10% |
Dec 31, 2022 | 233.16M | 70.13M | 43.01% |
Dec 31, 2021 | 163.03M | -58.75M | -26.49% |
Dec 31, 2020 | 221.79M | 19.76M | 9.78% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
NEUCA | 12.61B |
Synektik Spólka Akcyjna | 556.63M |
Voxel | 492.41M |
Celon Pharma | 209.54M |
Selvita | 345.76M |
Ryvu Therapeutics | 101.96M |
Centrum Medyczne ENEL-MED | 680.32M |
Scope Fluidics | 119.00K |